At1g48405 Antibody

What is At1g48405 and why is it significant for plant research?

At1g48405 is a protein encoded by the Arabidopsis thaliana genome, identified by the UniProt accession number Q9SX73. The significance of this protein lies in its potential role in plant developmental processes and stress responses, making it a valuable target for studies investigating plant physiology and molecular mechanisms. The antibody against At1g48405 enables researchers to detect, quantify, and localize this protein within plant tissues, facilitating investigations into its expression patterns, post-translational modifications, and functional relationships with other proteins. Understanding At1g48405's function contributes to our broader knowledge of plant molecular networks and potential applications in crop improvement research.

What are the recommended storage conditions for At1g48405 Antibody?

The At1g48405 Antibody should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can compromise antibody integrity and functionality. The antibody is supplied in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative, which helps maintain stability during storage. For research laboratories conducting long-term studies, it is advisable to aliquot the antibody into smaller volumes before freezing to minimize freeze-thaw cycles. When handling the antibody, always wear appropriate personal protective equipment and maintain sterile conditions to prevent contamination.

What applications has At1g48405 Antibody been validated for?

The At1g48405 Antibody has been tested and validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications. These techniques allow researchers to detect and quantify the target protein in different experimental contexts. In ELISA applications, the antibody can be used to quantitatively measure At1g48405 protein levels in plant extracts. For Western Blot applications, the antibody enables detection of the protein after separation by gel electrophoresis, providing information about protein size, abundance, and potential modifications. While these are the primary validated applications, researchers may optimize conditions for additional techniques such as immunohistochemistry or immunoprecipitation, though additional validation would be required for these applications.

How should I design positive and negative controls for experiments using At1g48405 Antibody?

For robust experimental design with At1g48405 Antibody, appropriate controls are essential:

Positive Controls:

• Recombinant At1g48405 protein: Since this was used as the immunogen for antibody production, it serves as an ideal positive control.

• Wild-type Arabidopsis thaliana tissues known to express At1g48405: Based on expression databases or previous literature.

• Overexpression systems: Arabidopsis lines overexpressing the At1g48405 gene.

Negative Controls:

• Knockout or knockdown Arabidopsis lines for At1g48405.

• Pre-immune serum: Serum collected from the same rabbit prior to immunization.

• Secondary antibody-only controls: Omitting the primary At1g48405 Antibody to check for non-specific binding.

• Competitive blocking: Pre-incubating the antibody with recombinant At1g48405 protein before application.

These controls help validate antibody specificity and experimental reliability, particularly important given that polyclonal antibodies may exhibit batch-to-batch variation. Systematic implementation of controls ensures confident interpretation of experimental results, especially when investigating proteins with potential homologs or when developing novel applications.

How can I optimize At1g48405 Antibody for cross-species reactivity testing?

Optimizing At1g48405 Antibody for cross-species reactivity requires a systematic approach based on sequence homology and epitope conservation:

• Sequence Alignment Analysis: Begin by performing multiple sequence alignments of At1g48405 protein across target plant species using tools like BLASTP or Clustal Omega. Focus particularly on the immunogen sequence region used to generate the antibody (recombinant Arabidopsis thaliana At1g48405 protein).

• Epitope Prediction: Utilize bioinformatic approaches to predict potential epitopes within the immunogen sequence and evaluate their conservation across species. Tools like BepiPred or Ellipro can assist in identifying likely B-cell epitopes.

• Graduated Dilution Series: When testing cross-reactivity experimentally, employ a wider dilution series than typically used for Arabidopsis (e.g., 1:100 to 1:10,000) to account for potential affinity differences.

• Modified Blocking Conditions: For species with lower sequence homology, consider increasing blocking stringency (5-10% BSA or 5% milk) and including 0.1-0.5% Triton X-100 to reduce background.

• Alternative Detection Methods: For species with potential lower affinity, enhance sensitivity by utilizing signal amplification systems such as biotin-streptavidin or tyramide signal amplification.

This methodical approach maximizes the potential utility of the At1g48405 Antibody beyond its primary target species while maintaining experimental rigor and interpretation confidence.

What strategies can improve At1g48405 Antibody specificity when working with complex plant tissue extracts?

When working with complex plant tissue extracts, several strategies can significantly improve At1g48405 Antibody specificity:

• Sample Pre-clearing: Incubate tissue extracts with protein A/G beads prior to immunoprecipitation to remove components that bind non-specifically to the beads. This can be followed by pre-incubation with non-immune rabbit IgG to remove proteins that might bind non-specifically to IgG.

• Subcellular Fractionation: Perform differential centrifugation to isolate specific cellular compartments where At1g48405 is expected to localize, thereby reducing the complexity of the protein mixture before antibody application.

• Modified Extraction Buffers: Enhance extraction specificity by optimizing buffer composition:

  • Include 0.1-1% NP-40 or Triton X-100 to reduce hydrophobic interactions

  • Add 150-300 mM NaCl to disrupt ionic interactions

  • Include 5-10 mM EDTA to chelate divalent cations that might mediate non-specific binding

  • Add protease inhibitors to prevent degradation of target proteins

• Sequential Epitope Exposure: For particularly challenging samples, consider a sequential antigen retrieval protocol that combines both heat-mediated and enzymatic methods to maximize epitope accessibility while preserving tissue structure.

• Two-dimensional Immunoblotting: Separate proteins by both isoelectric point and molecular weight before immunoblotting to significantly enhance specificity by precisely identifying the target protein.

These approaches, individually or in combination, can substantially improve signal-to-noise ratio and confidence in identifying specifically bound At1g48405 protein in complex plant samples.

How can I adapt immunoprecipitation protocols for At1g48405 to identify protein interaction partners?

Adapting immunoprecipitation (IP) protocols for At1g48405 to identify protein interaction partners requires careful optimization to maintain native protein complexes while achieving sufficient specificity:

• Crosslinking Optimization: Implement a titration of formaldehyde (0.1-1%) or DSP (dithiobis(succinimidyl propionate)) concentrations with varying crosslinking times (5-30 minutes) to stabilize transient protein interactions while avoiding over-crosslinking that can impede antibody recognition.

• Extraction Buffer Formulation: Develop a specialized buffer containing:

  • 20-50 mM HEPES or Tris (pH 7.5) for physiological pH maintenance

  • 100-150 mM NaCl to preserve electrostatic interactions

  • 0.5-1% NP-40 or 0.5% Triton X-100 for moderate membrane disruption

  • 10% glycerol to stabilize protein structure

  • 1mM EDTA, 1mM EGTA, 5mM NaF, 1mM Na₃VO₄ as phosphatase inhibitors

  • Complete protease inhibitor cocktail

• Sequential Elution Strategy: Implement a multi-step elution protocol to separate weakly and strongly associated partners:

  • Initial elution with increasing salt concentrations (150mM to 500mM NaCl)

  • Secondary elution with mild detergent (0.1% SDS)

  • Final elution under denaturing conditions

• Validation Through Reciprocal IP: Confirm identified interactions by performing reverse immunoprecipitation with antibodies against the potential interacting partners identified through mass spectrometry.

• Controls for Specificity: Include parallel IPs with:

  • Pre-immune serum

  • IgG from the same species

  • Lysates from At1g48405 knockout lines

This comprehensive approach allows for the identification of both stable and transient interaction partners of At1g48405, providing insights into its functional networks in plant cellular processes.

What are the optimal mass spectrometry preparation methods for At1g48405 Antibody-mediated immunoprecipitation samples?

To achieve optimal mass spectrometry (MS) results from At1g48405 Antibody-mediated immunoprecipitation samples, the following specialized preparation methods are recommended:

• On-Bead Digestion Protocol:

  • After immunoprecipitation, wash beads 3x with 50mM ammonium bicarbonate

  • Reduce proteins with 5mM DTT at 56°C for 30 minutes

  • Alkylate with 15mM iodoacetamide in darkness for 30 minutes

  • Digest directly on beads using MS-grade trypsin (1:50 enzyme:protein ratio) overnight at 37°C

  • Extract peptides with 50% acetonitrile/5% formic acid

  • Dry samples using vacuum centrifugation

• Sample Clean-up Optimization:

  • For low-abundance samples, implement STAGE-tip purification using C18 material

  • For complex samples, consider high-pH reversed-phase fractionation to increase depth of detection

  • Remove detergents with Pierce Detergent Removal Spin Columns before MS analysis

• Plant-Specific Considerations:

  • Include polyvinylpolypyrrolidone (PVPP) in initial extraction buffers to remove plant phenolic compounds

  • Consider additional precipitation steps (TCA/acetone) to eliminate plant pigments and secondary metabolites that may interfere with MS analysis

• Cross-linking Mass Spectrometry (XL-MS) Adaptation:

  • For interaction interface mapping, incorporate MS-compatible crosslinkers like DSS or BS3

  • Modify digestion protocols to include multiple proteases (trypsin followed by GluC) to improve crosslinked peptide identification

• Data Acquisition Strategy:

  • Implement parallel reaction monitoring (PRM) for targeted analysis of At1g48405 and predicted interactors

  • Use data-independent acquisition (DIA) for broad coverage of potential interactors

These specialized approaches ensure high-quality mass spectrometry data that can reliably identify both the target protein and its interaction partners while minimizing plant-specific analytical challenges.

What concentrations and incubation conditions are optimal for different applications of At1g48405 Antibody?

Optimal working conditions for At1g48405 Antibody vary significantly across different applications. The following table provides evidence-based recommendations derived from experimental validations:

Note: Applications marked with asterisk () require additional validation as they are not explicitly listed in the primary technical documentation for this antibody.

These conditions serve as starting points and may require optimization based on specific experimental contexts, sample types, and detection methods. For particularly challenging samples or novel applications, a gradient dilution test is recommended to identify optimal antibody concentration.

How should I design experiments to verify At1g48405 Antibody specificity in my experimental system?

Verifying At1g48405 Antibody specificity in your experimental system requires a multi-faceted approach:

• Genetic Controls:

  • Compare signal between wild-type and At1g48405 knockout/knockdown plants

  • Test antibody reactivity with tissues from plants overexpressing At1g48405

  • Evaluate expression patterns against established transcriptomic data

• Biochemical Validation:

  • Perform peptide competition assays by pre-incubating the antibody with excess immunogenic peptide/protein

  • Conduct depletion experiments using affinity purification with recombinant At1g48405

  • Run parallel assays with antibodies against different epitopes of the same protein, if available

• Technical Validation:

  • Analyze band patterns on Western blots for consistency with predicted molecular weight

  • Conduct 2D-gel electrophoresis followed by immunoblotting to verify isoelectric point and mass

  • Perform mass spectrometry validation of immunoprecipitated samples

• Physiological Correlation:

  • Correlate antibody-detected expression patterns with known physiological conditions that regulate At1g48405

  • Examine protein levels under conditions known to affect transcription (e.g., stress treatments, developmental stages)

• Experimental Thoroughness:

  • Include gradient loading controls to verify signal linearity

  • Test multiple tissue types and developmental stages to establish expression patterns

  • Evaluate background signal under varying blocking conditions and antibody concentrations

This comprehensive validation framework ensures confidence in the specificity of signal detection and supports reliable interpretation of experimental results.

What approaches can detect post-translational modifications of At1g48405 using this antibody?

Detecting post-translational modifications (PTMs) of At1g48405 requires specialized approaches that extend beyond standard immunodetection. The following methodologies can be implemented using the At1g48405 Antibody:

• Mobility Shift Assays:

  • Utilize high-percentage (10-15%) or gradient SDS-PAGE gels to resolve small mass changes caused by PTMs

  • Implement Phos-tag™ acrylamide gels for enhanced separation of phosphorylated forms

  • Compare migration patterns before and after treatment with specific modification-removing enzymes:

    • Phosphatase for phosphorylation

    • Deglycosylation enzymes (PNGase F, Endo H) for glycosylation

    • SUMO/ubiquitin proteases for SUMOylation/ubiquitination

• Two-dimensional Electrophoresis:

  • Separate proteins first by isoelectric point, then by molecular weight

  • Compare spot patterns with theoretical migration to identify charge and mass shifts indicative of PTMs

• Immunoprecipitation-Based Approaches:

  • Perform IP with At1g48405 Antibody followed by immunoblotting with PTM-specific antibodies:

    • Anti-phospho-Ser/Thr/Tyr for phosphorylation

    • Anti-ubiquitin/SUMO for ubiquitination/SUMOylation

    • Anti-acetyl-Lys for acetylation

  • Co-IP to detect interaction with known modification enzymes (kinases, ubiquitin ligases)

• MS-Based PTM Mapping:

  • Perform IP with At1g48405 Antibody followed by LC-MS/MS analysis

  • Implement neutral loss scanning for phosphorylation (loss of 98 Da)

  • Utilize electron transfer dissociation (ETD) for improved PTM site localization

  • Apply Selected Reaction Monitoring (SRM) for quantitative tracking of modified peptides

• Chemical Biology Approaches:

  • Pre-treat samples with PTM-enhancing compounds (phosphatase inhibitors, deacetylase inhibitors)

  • Use click chemistry combined with bioorthogonal labeling to detect specific modifications

These methodologies can reveal critical information about the regulation and function of At1g48405 through its post-translational modification landscape.

How can I address low signal or high background issues when working with At1g48405 Antibody?

Addressing signal and background issues with At1g48405 Antibody requires systematic troubleshooting strategies:

For particularly challenging samples from Arabidopsis thaliana, consider tissue-specific extraction modifications and verification with alternative detection methods to confirm results.

What are the quantitative analysis methods for At1g48405 protein expression data?

For robust quantitative analysis of At1g48405 protein expression data, implement the following methodological approaches:

• Western Blot Densitometry Analysis:

  • Generate standard curves using recombinant At1g48405 protein (1-100 ng range)

  • Employ gradient loading of samples to verify linear detection range

  • Normalize signal to multiple housekeeping proteins (e.g., actin, tubulin, and GAPDH) to account for loading variations

  • Analyze using software with background subtraction capabilities (ImageJ, Image Lab, or LI-COR Image Studio)

  • Apply rolling ball background correction algorithm (50-100 pixel radius) for plant samples with variable backgrounds

• ELISA Quantification:

  • Develop a sandwich ELISA using the At1g48405 Antibody as capture antibody

  • Generate standard curves with 4-parameter logistic regression

  • Implement technical triplicates and biological replicates (minimum n=3)

  • Calculate inter- and intra-assay coefficients of variation (CV < 15% for acceptance)

• Statistical Analysis Framework:

  • Apply appropriate normality tests before selecting parametric or non-parametric methods

  • For time-course experiments, utilize repeated measures ANOVA with post-hoc corrections

  • For treatment comparisons, implement two-way ANOVA with interaction analysis

  • Calculate effect sizes (Cohen's d) alongside p-values for biological significance

• Software and Visualization:

  • R packages (ggplot2, limma) for consistent data presentation

  • Implement hierarchical clustering for multi-condition experiments

  • Visualize with boxplots showing individual data points rather than bar graphs

  • Generate heat maps for tissue-specific or condition-specific expression patterns

• Meta-analysis Integration:

  • Correlate protein abundance with published transcriptomic data

  • Implement Bayesian integration methods for multi-omics data synthesis

  • Calculate Pearson or Spearman correlations between protein levels and phenotypic measurements

These approaches ensure rigorous quantification of At1g48405 protein levels while maintaining statistical validity and biological relevance.

How can I integrate At1g48405 Antibody data with transcriptomics and proteomics datasets?

Integrating At1g48405 Antibody-derived data with larger -omics datasets requires sophisticated computational approaches:

• Multi-omics Data Preparation:

  • Normalize antibody-quantified protein levels using global normalization methods (e.g., VSN or quantile normalization)

  • Transform transcriptomic data (log2 or variance stabilizing transformation) for comparability

  • Account for different dynamic ranges between antibody data and mass spectrometry data through z-score normalization

  • Implement missing value imputation strategies tailored to proteomics data characteristics (e.g., k-nearest neighbor imputation)

• Correlation Analysis Framework:

  • Calculate protein-mRNA correlations using both Pearson (linear) and Spearman (rank-based) methods

  • Generate protein-protein correlation networks using weighted correlation network analysis (WGCNA)

  • Identify discordant patterns between protein and transcript levels to discover post-transcriptional regulation

  • Implement time-lag analyses for time-course experiments to account for delayed protein synthesis

• Pathway and Network Analysis:

  • Map At1g48405 and its interacting partners to known plant pathways (KEGG, Plant Reactome)

  • Apply gene set enrichment analysis (GSEA) to identify functional categories correlating with At1g48405 expression

  • Construct protein-protein interaction networks integrating antibody-derived co-IP data with public interactome databases

  • Implement network propagation algorithms to predict functional associations

• Visualization Strategies:

  • Generate multi-layer circos plots integrating protein, transcript, and phenotypic data

  • Implement t-SNE or UMAP dimensionality reduction for complex multi-omics visualization

  • Create interactive networks using platforms like Cytoscape with custom data integration plugins

  • Develop horizon plots for visualizing temporal changes across multiple data types

• Statistical Integration Methods:

  • Implement Bayesian factor analysis for formally combining evidence across data types

  • Apply DIABLO (Data Integration Analysis for Biomarker discovery using Latent cOmponents) for supervised integration

  • Utilize similarity network fusion (SNF) to integrate multiple data types based on patient/sample networks

  • Calculate information content and weighting schemes for different data types

This comprehensive integration framework allows researchers to place At1g48405 findings within broader molecular contexts, enabling systems-level understanding of its biological roles.